P. Wen and S. Kesari, Malignant Gliomas in Adults, New England Journal of Medicine, vol.359, issue.5, pp.492-507, 2008.
DOI : 10.1056/NEJMra0708126

M. Siker, M. Wang, K. Porter, D. Nelson, and W. Curran, Age as an independent prognostic factor in patients with glioblastoma: a radiation therapy oncology group and American College of Surgeons National Cancer Data Base comparison, Journal of Neuro-Oncology, vol.11, issue.1, pp.351-356, 2011.
DOI : 10.1007/s11060-010-0500-6

W. Stummer, M. Van-den-bent, and M. Westphal, Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion, Acta Neurochirurgica, vol.88, issue.3 Suppl, pp.1211-1218, 2011.
DOI : 10.1007/s00701-011-1001-x

G. Filippini, C. Falcone, A. Boiardi, G. Broggi, and M. Bruzzone, Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma, Neuro-Oncology, vol.10, issue.1, pp.79-87, 2008.
DOI : 10.1215/15228517-2007-038

K. Ichimura, D. Pearson, S. Kocialkowski, L. Backlund, and R. Chan, IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas, Neuro-Oncology, vol.11, issue.4, pp.341-347, 2009.
DOI : 10.1215/15228517-2009-025

H. Yan, D. Parsons, J. G. Mclendon, R. Rasheed, and B. , Mutations in Gliomas, New England Journal of Medicine, vol.360, issue.8, pp.765-773, 2009.
DOI : 10.1056/NEJMoa0808710

M. Sanson, Y. Marie, S. Paris, A. Idbaih, and J. Laffaire, Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas, Journal of Clinical Oncology, vol.27, issue.25, pp.4150-4154, 2009.
DOI : 10.1200/JCO.2009.21.9832

R. Stupp, M. Hegi, W. Mason, M. Van-den-bent, and M. Taphoorn, Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, The Lancet Oncology, vol.10, issue.5, pp.459-466, 2009.
DOI : 10.1016/S1470-2045(09)70025-7

T. Gorlia, M. Van-den-bent, M. Hegi, R. Mirimanoff, and M. Weller, Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3, The Lancet Oncology, vol.9, issue.1, pp.29-38, 2008.
DOI : 10.1016/S1470-2045(07)70384-4

A. Etcheverry, M. Aubry, M. De-tayrac, E. Vauleon, and R. Boniface, DNA methylation in glioblastoma: impact on gene expression and clinical outcome., BMC Genomics, vol.11, issue.1, p.701, 2010.
DOI : 10.1186/1471-2164-11-701
URL : https://hal.archives-ouvertes.fr/inserm-00663706

D. Regier, J. Higbee, K. Lund, F. Sakane, and S. Prescott, Diacylglycerol kinase ?? regulates Ras guanyl-releasing protein 3 and inhibits Rap1 signaling, Proceedings of the National Academy of Sciences, vol.102, issue.21, pp.7595-7600, 2005.
DOI : 10.1073/pnas.0500663102

M. Kang, M. Kim, J. Oh, Y. Kim, and S. Song, Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers, International Journal of Cancer, vol.279, issue.2, pp.353-355, 2009.
DOI : 10.1002/ijc.24379

S. Turcan, D. Rohle, A. Goenka, L. Walsh, and F. Fang, IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype, Nature, vol.25, issue.7390, pp.479-483, 2012.
DOI : 10.1038/nature10866

V. Quillien, A. Lavenu, L. Karayan-tapon, C. Carpentier, and M. Labussiere, Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, methylight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA- methyltranferase in a series of 100 glioblastoma patients, Cancer, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00667080

R. Stupp, W. Mason, M. Van-den-bent, M. Weller, and B. Fisher, Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005.
DOI : 10.1056/NEJMoa043330

C. Parks, J. Heald, and G. Hall, Kamaly-Asl I (2013) Can the prognosis of individual patients with glioblastoma be predicted using an online calculator?

K. Revill, T. Wang, A. Lachenmayer, K. Kojima, and A. Harrington, Genome-Wide Methylation Analysis and Epigenetic Unmasking Identify Tumor Suppressor Genes in Hepatocellular Carcinoma, Gastroenterology, vol.145, issue.6, pp.1424-1435, 2013.
DOI : 10.1053/j.gastro.2013.08.055